HOBOKEN -- The state attorney general's office will look into the soaring retail price of the heroin overdose antidote Narcan, acting Attorney General Robert Lougy told NJ Advance Media on Monday.

Appearing at Hoboken University Medical Center Monday afternoon at a training session for friends and family members who might need to administer the opioid antidote to drug abusers who'd overdosed, Gov. Chris Christie touted Narcan as a crucial first step in getting people from addiction to detox.

"Narcan has saved thousands of lives in New Jersey," Christie said. "People who otherwise would have died of an overdose if someone hadn't been prepared and trained with the antidote."

When Christie was asked about the Narcan price increases on Monday, and whether they merited revisiting New Jersey's agreement from last June, the governor answered simply, "Don't know."

But Lougy, the governor's newly-appointed acting attorney general, told NJ Advance Media that his office, which operates independently of the governor's, will be taking a closer look both at his predecessor's agreement with Amphastar and the pharmaceutical company's rationale for its explosive Narcan pricing hikes.

Meanwhile, the cost of Narcan continues to soar in other nearby states, like Maryland.

"In May 2014, a 10-dose pack (of Narcan) cost the Baltimore City Health Department roughly $190," said U.S. Rep. Elijah Cummings of Maryland in his opening remarks at a House Committee on Oversight and Government Reform hearing on the heroin epidemic last month. "Guess what? Today, it costs more than $400 for a life-saving drug."

Claude Brodesser-Akner may be reached at cbrodesser@njadvancemedia.com. Follow him on Twitter @ClaudeBrodesser. Find NJ.com Politics on Facebook.